Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction

Kenji Tsuchihashi, Hozumi Shimokawa, Kotoe Takayoshi, Kenta Nio, Tomomi Aikawa, Yuzo Matsushita, Iori Wada, Shuji Arita, hiroshi ariyama, Hitoshi Kusaba, Kohei Sonoda, Koichi Akashi, Eishi Baba

Research output: Contribution to journalArticle

Abstract

Rationale: Regorafenib is effective for metastatic colorectal cancer but its toxicity such as hemorrhage should be considered. The safety of regorafenib for the patient with the liver disease is not known. Patient concerns: Seventy-one-year old man of colon cancer had myodesopsia and blood stool after 14 days from the initiation of regorafenib administration with 50% dose reduction due to liver dysfunction. Diagnoses: Fundus examination revealed hemorrhage of the retinal vein. Interventions: Regorafenib treatment was discontinued and observational therapy was pursued. Outcomes: Retinal and gastrointestinal hemorrhage resolved in 1 week. Lessons: Retinal hemorrhage should be considered as the differential diagnosis of myodesopsia in the patient treated by regorafenib. Safety and pharmacokinetic of continuous regorafenib administration for patients with liver dysfunction remains to be clarified.

Original languageEnglish
Article numbere8285
JournalMedicine (United States)
Volume96
Issue number42
DOIs
Publication statusPublished - Oct 1 2017

Fingerprint

Retinal Hemorrhage
Gastrointestinal Hemorrhage
Liver Diseases
Colorectal Neoplasms
Hemorrhage
Retinal Vein
Patient Safety
Colonic Neoplasms
regorafenib
Differential Diagnosis
Pharmacokinetics
Safety
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction. / Tsuchihashi, Kenji; Shimokawa, Hozumi; Takayoshi, Kotoe; Nio, Kenta; Aikawa, Tomomi; Matsushita, Yuzo; Wada, Iori; Arita, Shuji; ariyama, hiroshi; Kusaba, Hitoshi; Sonoda, Kohei; Akashi, Koichi; Baba, Eishi.

In: Medicine (United States), Vol. 96, No. 42, e8285, 01.10.2017.

Research output: Contribution to journalArticle

@article{9c2d719d969c4ee7a68b8b93b45fe07f,
title = "Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction",
abstract = "Rationale: Regorafenib is effective for metastatic colorectal cancer but its toxicity such as hemorrhage should be considered. The safety of regorafenib for the patient with the liver disease is not known. Patient concerns: Seventy-one-year old man of colon cancer had myodesopsia and blood stool after 14 days from the initiation of regorafenib administration with 50{\%} dose reduction due to liver dysfunction. Diagnoses: Fundus examination revealed hemorrhage of the retinal vein. Interventions: Regorafenib treatment was discontinued and observational therapy was pursued. Outcomes: Retinal and gastrointestinal hemorrhage resolved in 1 week. Lessons: Retinal hemorrhage should be considered as the differential diagnosis of myodesopsia in the patient treated by regorafenib. Safety and pharmacokinetic of continuous regorafenib administration for patients with liver dysfunction remains to be clarified.",
author = "Kenji Tsuchihashi and Hozumi Shimokawa and Kotoe Takayoshi and Kenta Nio and Tomomi Aikawa and Yuzo Matsushita and Iori Wada and Shuji Arita and hiroshi ariyama and Hitoshi Kusaba and Kohei Sonoda and Koichi Akashi and Eishi Baba",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/MD.0000000000008285",
language = "English",
volume = "96",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "42",

}

TY - JOUR

T1 - Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction

AU - Tsuchihashi, Kenji

AU - Shimokawa, Hozumi

AU - Takayoshi, Kotoe

AU - Nio, Kenta

AU - Aikawa, Tomomi

AU - Matsushita, Yuzo

AU - Wada, Iori

AU - Arita, Shuji

AU - ariyama, hiroshi

AU - Kusaba, Hitoshi

AU - Sonoda, Kohei

AU - Akashi, Koichi

AU - Baba, Eishi

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Rationale: Regorafenib is effective for metastatic colorectal cancer but its toxicity such as hemorrhage should be considered. The safety of regorafenib for the patient with the liver disease is not known. Patient concerns: Seventy-one-year old man of colon cancer had myodesopsia and blood stool after 14 days from the initiation of regorafenib administration with 50% dose reduction due to liver dysfunction. Diagnoses: Fundus examination revealed hemorrhage of the retinal vein. Interventions: Regorafenib treatment was discontinued and observational therapy was pursued. Outcomes: Retinal and gastrointestinal hemorrhage resolved in 1 week. Lessons: Retinal hemorrhage should be considered as the differential diagnosis of myodesopsia in the patient treated by regorafenib. Safety and pharmacokinetic of continuous regorafenib administration for patients with liver dysfunction remains to be clarified.

AB - Rationale: Regorafenib is effective for metastatic colorectal cancer but its toxicity such as hemorrhage should be considered. The safety of regorafenib for the patient with the liver disease is not known. Patient concerns: Seventy-one-year old man of colon cancer had myodesopsia and blood stool after 14 days from the initiation of regorafenib administration with 50% dose reduction due to liver dysfunction. Diagnoses: Fundus examination revealed hemorrhage of the retinal vein. Interventions: Regorafenib treatment was discontinued and observational therapy was pursued. Outcomes: Retinal and gastrointestinal hemorrhage resolved in 1 week. Lessons: Retinal hemorrhage should be considered as the differential diagnosis of myodesopsia in the patient treated by regorafenib. Safety and pharmacokinetic of continuous regorafenib administration for patients with liver dysfunction remains to be clarified.

UR - http://www.scopus.com/inward/record.url?scp=85032647234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032647234&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000008285

DO - 10.1097/MD.0000000000008285

M3 - Article

VL - 96

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 42

M1 - e8285

ER -